Search
Search
In vitro assays and diagnostic technologies have developed rapidly in recent years, from gene sequencing, single nucleotide polymorphism (SNP) screening, and point mutation gene diagnosis at the gene level, to various biomarkers at the protein level, to circulating tumor cell detection (CTC) and thin layer liquid-based cytology (TCT) at the cellular level, and to PET/CT at the tissue level. In vitro assays play a vital role and are indispensable tools in the prevention, diagnosis, monitoring, and treatment of brain tumors.
In vitro assays are evolving to be simpler, faster, non-invasive, and multi-informative. Alfa Cytology offers a variety of in vitro assays for brain tumors using multiple methods at multiple levels and stages of disease development. By measuring CTC, circulating tumor DNA (ctDNA) and tumor cell exosomes in samples such as blood, early screening, guiding treatment planning, treatment monitoring and recurrence monitoring of brain tumor patients can be achieved.
We offer an in vitro antibody functional activity assay service for ADCC, CDC, and ADCP in brain tumor research to detect and evaluate the efficacy of antibodies or target cells.
We provide high-quality results through GPCRs binding assays and functional analysis assay services to accelerate our clients' new drug discovery and development in brain tumors.
We offer brain tumor cytokine analysis services to our clients, and we provide methods including cell biology assays, molecular biology assays, and immunology assays. Cytokines that can be tested include interferons, interleukins, lymphokines, and tumor necrosis factors.
We can provide brain tumor-related chemokine analysis services to our clients. We can analyze and quantify chemokines by single and multiplexed assays. We are also equipped with a high throughput flow cytometer that allows CBA immunoassays to achieve multiplex results from a single small number of samples.
We combine ELISA, microsphere technology, and flow cytometry to provide a high throughput assay for multiple growth factors in a small number of samples simultaneously. It saves samples and improves the efficiency of your research.
We provide our customers with efficient and stable antibody internalization assay solutions. In addition, our live cell imaging system provides a simple, integrated and quantitative solution for you to directly study the internalization of antibodies within cells.
We have built an easy-to-operate, sensitive, and specific assay solution based on our excellent project experience, which can be flexibly selected according to customers' experimental needs. In addition, we also offer brain tumor cell proliferation inhibitor screening services.
We offer a wide range of services including STR-based cell line identification and mycoplasma testing with the advantage of reliable data and short cycle times.
We can provide primary immune cells from a wide range of stimuli and different species to help our clients assess the in vitro activity of antibodies by detecting immune cell proliferation, and the expression of immune cell surface markers.
In vitro assays are used in all phases of brain tumor research, from the initial diagnosis to treatment selection, efficacy evaluation, and cure. Alfa Cytology can provide you with comprehensive and accurate in vitro assays for brain tumors, please feel free to contact us to discuss your project details.
Brain Tumors
Alfa Cytology has been committed to providing comprehensive services and products to our brain tumor research customers worldwide through our global network of operations.
Subscribe to Our Newsletter
Copyright © 2024 Alfa Cytology. All rights reserved.